Sartorius Aktiengesellschaft (SRT3) - Total Assets

Latest as of September 2025: €9.61 Billion EUR ≈ $11.24 Billion USD

Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT3) holds total assets worth €9.61 Billion EUR (≈ $11.24 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Sartorius Aktiengesellschaft for net asset value and shareholders' equity analysis.

Sartorius Aktiengesellschaft - Total Assets Trend (2002–2024)

This chart illustrates how Sartorius Aktiengesellschaft's total assets have evolved over time, based on quarterly financial data.

Sartorius Aktiengesellschaft - Asset Composition Analysis

Current Asset Composition (December 2024)

Sartorius Aktiengesellschaft's total assets of €9.61 Billion consist of 20.9% current assets and 79.1% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €813.40 Million 8.1%
Accounts Receivable €328.70 Million 3.3%
Inventory €788.50 Million 7.8%
Property, Plant & Equipment €2.35 Billion 23.2%
Intangible Assets €1.97 Billion 19.5%
Goodwill €3.50 Billion 34.7%

Asset Composition Trend (2002–2024)

This chart illustrates how Sartorius Aktiengesellschaft's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SRT3 market cap overview.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Sartorius Aktiengesellschaft's current assets represent 20.9% of total assets in 2024, a decrease from 49.7% in 2002.
  • Cash Position: Cash and equivalents constituted 8.1% of total assets in 2024, up from 3.5% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 53.0% of total assets, an increase from 7.0% in 2002.
  • Asset Diversification: The largest asset category is goodwill at 34.7% of total assets.

Sartorius Aktiengesellschaft Competitors by Total Assets

Key competitors of Sartorius Aktiengesellschaft based on total assets are shown below.

Company Country Total Assets
Alcon AG
SW:ALC
Switzerland CHF31.53 Billion
iRay Technology Co Ltd
SHG:688301
China CN¥11.33 Billion
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
China CN¥2.42 Billion
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
USA $32.49 Million
Jiangsu Nanfang Medical
SHG:603880
China CN¥993.46 Million
SDI Ltd
AU:SDI
Australia AU$141.20 Million
MEDIMI AB AK
F:79T
Germany €1.70 Million
I.Ceram SA
PA:ALICR
France €3.91 Million

Sartorius Aktiengesellschaft - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.95 2.02 1.39
Quick Ratio 0.49 1.13 0.76
Cash Ratio 0.22 0.00 0.00
Working Capital €-90.40 Million €992.10 Million €339.64 Million

Sartorius Aktiengesellschaft - Advanced Valuation Insights

This section examines the relationship between Sartorius Aktiengesellschaft's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.98
Latest Market Cap to Assets Ratio 0.87
Asset Growth Rate (YoY) 3.6%
Total Assets €10.10 Billion
Market Capitalization $8.84 Billion USD

Valuation Analysis

Near Book Valuation: The market values Sartorius Aktiengesellschaft's assets close to their book value (0.87x), suggesting investors view the company's assets at approximately fair value.

Positive Asset Growth: Sartorius Aktiengesellschaft's assets grew by 3.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Sartorius Aktiengesellschaft (2002–2024)

The table below shows the annual total assets of Sartorius Aktiengesellschaft from 2002 to 2024.

Year Total Assets Change
2024-12-31 €10.10 Billion
≈ $11.81 Billion
+3.56%
2023-12-31 €9.76 Billion
≈ $11.40 Billion
+39.81%
2022-12-31 €6.98 Billion
≈ $8.16 Billion
+22.46%
2021-12-31 €5.70 Billion
≈ $6.66 Billion
+21.30%
2020-12-31 €4.70 Billion
≈ $5.49 Billion
+65.15%
2019-12-31 €2.84 Billion
≈ $3.33 Billion
+12.56%
2018-12-31 €2.53 Billion
≈ $2.95 Billion
+9.97%
2017-12-31 €2.30 Billion
≈ $2.69 Billion
+31.07%
2016-12-31 €1.75 Billion
≈ $2.05 Billion
+21.97%
2015-12-31 €1.44 Billion
≈ $1.68 Billion
+12.95%
2014-12-31 €1.27 Billion
≈ $1.49 Billion
+8.35%
2013-12-31 €1.17 Billion
≈ $1.37 Billion
+9.65%
2012-12-31 €1.07 Billion
≈ $1.25 Billion
+11.12%
2011-12-31 €963.84 Million
≈ $1.13 Billion
+19.33%
2010-12-31 €807.74 Million
≈ $944.33 Million
-1.55%
2009-12-31 €820.42 Million
≈ $959.16 Million
-5.15%
2008-12-31 €865.00 Million
≈ $1.01 Billion
+10.34%
2007-12-31 €783.93 Million
≈ $916.50 Million
+107.75%
2006-12-31 €377.34 Million
≈ $441.15 Million
+2.97%
2005-12-31 €366.45 Million
≈ $428.41 Million
+2.66%
2004-12-31 €356.96 Million
≈ $417.32 Million
-2.52%
2003-12-31 €366.19 Million
≈ $428.12 Million
-8.02%
2002-12-31 €398.14 Million
≈ $465.47 Million
--

About Sartorius Aktiengesellschaft

XETRA:SRT3 Germany Medical Instruments & Supplies
Market Cap
$8.84 Billion
€7.56 Billion EUR
Market Cap Rank
#2442 Global
#499 in Germany
Share Price
€217.20
Change (1 day)
+4.02%
52-Week Range
€177.50 - €265.30
All Time High
€601.63
About

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more